Advanced Prostate Cancer VL

Over-treatment in the Name of Cure: Revisiting Adjuvant Therapy in the Modern Era? - Christopher Sweeney

Details
(Length of discussion - 26 minutes) Christopher Sweeney, MD presents on the Over-treatment in the Name of Cure: Revisiting Adjuvant Therapy in the Modern Era? Dr. Sweeney addresses how we can cure more men from prostate cancer by taking a look at preventing relapse after definitive local therapy and radiation and hormonal therapy together vs radiation therapy alone. He reflects on the length of ti...

Navigating the Adverse Effects of ADT: Improving Patient Outcomes - Jehonathan Pinthus and Neal Shore

Details
E. David Crawford hosts a discussion with Neal Shore and Jehonathan Pinthus on the adverse effects of androgen deprivation therapy (ADT). Viewers will gain knowledge on the optimal role of the antagonist vs agonist and a closer look at adverse effects of ADT and recommendations for patients undergoing ADT. The notion of sarcopenia and recommendations in fitness and strength training to reduce risk...

Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer?- Lorelei Mucci

Details
(Length of lecture ~ 19 minutes) Alicia Morgans hosts a discussion with Lorelei Mucci on her recently-published article in the Journal of Clinical Oncology that reviews a study on the association between statin use and the mortality rate in Danish patients who have prostate cancer. This study leverages the unique data sets available in Scandinavian countries where nationwide health registers can b...

What the Referring Clinician Needs to Know from Molecular Imaging in Prostate Cancer - Felix Feng

Details
(Length of lecture ~ 16 minutes) Dr. Feng provides a brief overview of prostate cancer management and how molecular imaging approaches can help guide the clinical management of prostate cancer, noting that imaging physicians need to educate their clinical colleagues about capabilities and limitations of these imaging studies. Additional content on molecular imaging ASCO 2017: How Advances in Molec...

Bones, Hot Flashes and ADT: Using with Chemotherapy and Timing - Thomas Keane

Details
(Length of video ~17 min) Thomas Keane discusses strategies to mitigate side effects of ADT therapy and the difference between intermittent vs continuous ADT therapy. Dr. Keane focuses his lecture on the side effect of hot flashes while undergoing ADT therapy and recommendations for the management of hot flashes. Also, discussed is bone health and the acceleration of bone loss in men during ADT th...

Plasma based Biomarkers in Advanced Prostate Cancer - Gerhardt Attard

Details
Gerhardt Attard focuses on DNA Plasma-based biomarkers in advanced prostate cancer (16 minute presentation). He presents the rationale for using plasma DNA. Plasma collection is routine and are adding to the registries allows for ongoing clinical trials. Circulating tumor DNA is detected in plasma from ALL progressing mCRPC patients. Plasma DNA is representative of clinically relevant progressing...

APCCC 2017: Interview With Howard Soule

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage A Look at the Prostate Cancer Foundation Its History and Contributions to Medical Progress: Interview with Stuart Holden

ADT Impact on Cardiovascular Health - Jehonathan Pinthus

Details
The impact of androgen deprivation therapy (ADT) on cardiovascular health Biographies: Thomas E. Keane Jehonathan H. Pinthus, MD, PhD, FRCSC is a surgical oncologist-urologist and ssociate Professor in the Department of Surgery Division of Urology McMaster University. He is heading a basic and translational research laboratory at McMaster University and his research interests relates to the patien...

Patient-Reported Outcomes (PROs): Personalizing Care in Clinical Practice - Alicia Morgans

Details
Patient-Reported Outcomes (PRO): Personalizing Care in Clinical Practice Biography: Alicia Morgans, MD, MPH Related Content: Tools for predicting patient-reported outcomes (PROs): Optimizing Use in Clinical Practice